WestEnd Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56K Hold
7
– – ﹤0.01% 237
2026
Q2
$1.66K Buy
7
+1
+17% +$208 ﹤0.01% 209
2026
Q1
$1.27K Hold
6
– – ﹤0.01% 206
2025
Q4
$1.23K Sell
6
-1
-14% -$188 ﹤0.01% 208
2025
Q3
$1.1K Sell
7
-3
-30% -$463 ﹤0.01% 219
2025
Q2
$1.68K Buy
10
+1
+11% +$148 ﹤0.01% 162
2025
Q1
$1.24K Buy
9
+6
+200% +$765 ﹤0.01% 192
2024
Q4
$355 Hold
3
– – ﹤0.01% 208
2024
Q3
$332 Hold
3
– – ﹤0.01% 233
2024
Q2
$295 Sell
3
-1
-25% -$102 ﹤0.01% 218
2024
Q1
$448 Hold
4
– – ﹤0.01% 158
2023
Q4
$403 Hold
4
– – ﹤0.01% 173
2023
Q3
$347 Buy
+4
New +$362 ﹤0.01% 182
2023
Q1
– Sell
-3
Closed -$226 – 222
2022
Q4
$231 Hold
3
– – ﹤0.01% 215
2022
Q3
$0 Hold
3
– – ﹤0.01% 163
2022
Q2
$156 Buy
+3
New +$171 ﹤0.01% 238
2022
Q1
– Sell
-2
Closed -$107 – 247
2021
Q4
$102 Buy
+2
New +$98 ﹤0.01% 345
2021
Q3
– Hold
0
– – – 332
2021
Q2
– Hold
0
– – – 316
2019
Q4
– Sell
-52
Closed -$2.45K – 60
2019
Q3
$2.45K Buy
+52
New +$2.37K ﹤0.01% 56

Other funds holding CAH

WestEnd Advisors's CAH Position: Q3 2026 in Review

WestEnd Advisors held its Cardinal Health (CAH) position steady in Q3 2026 at 7 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #237.

WestEnd Advisors first reported a position in CAH in Q3 2019 and has held it in 18 quarters since. The position peaked at $2.45K in Q3 2019. 806 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • WestEnd Advisors held 7 shares of Cardinal Health worth $1.56K as of Q3 2026.
  • WestEnd Advisors left its Cardinal Health share count unchanged in Q3 2026.
  • Cardinal Health made up ﹤0.01% of WestEnd Advisors's portfolio in Q3 2026, its #237 holding.
  • WestEnd Advisors first reported a position in Cardinal Health in Q3 2019 and has held it in 18 quarters since.
  • WestEnd Advisors's Cardinal Health position peaked at $2.45K in Q3 2019.
  • 806 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.